Armistice Capital, LLC 4 D Molecular Therapeutics, Inc. Transaction History

Armistice Capital, LLC

  • $6.51 Billion
  • Q3 2025

A detailed history of Armistice Capital, LLC transactions in 4 D Molecular Therapeutics, Inc. stock. As of the latest transaction made, Armistice Capital, LLC holds 1,096,000 shares of FDMT stock, worth $11.9 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares
1,096,000
Previous 300,000 265.33%
Holding current value
$11.9 Million
Previous $1.11 Million 729.11%
% of portfolio
0.14%
Previous 0.02%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025
BUY
$3.95 - $8.44 $3.14 Million - $6.72 Million
796,000 Added 265.33%
1,096,000 $9.23 Million
Q4 2024

Feb 14, 2025
SELL
$5.3 - $10.41 $190,800 - $374,760
-36,000 Reduced 10.71%
300,000 $1.67 Million
Q3 2024

Nov 14, 2024
BUY
$10.81 - $27.22 $3.63 Million - $9.15 Million
336,000 New
336,000 $3.63 Million

About 4D Molecular Therapeutics, Inc.

FDMT Quotes by TradingView
  • Ticker FDMT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 32,382,400
  • Market Cap $351M
  • Description
  • 4D Molecular Therapeutics, Inc., a clinical-stage gene therapy company, develops product candidates using its adeno-associated viruses vectors. It develops a portfolio of gene therapy product candidates focuses in three therapeutic areas: ophthalmology, cardiology, and pulmonology. The company has three product candidates that are in clinical tr...
More about FDMT
Track This Portfolio

Track Armistice Capital, LLC Portfolio

Follow Armistice Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Armistice Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Armistice Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email